Combination of HSP90 Inhibitors and HSP70 Inducers Prevent Hydrochloric Acid-Induced Pulmonary Fibrosis in Rabbits
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020441 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ruben M L Colunga Biancatelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA 23508, USA. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Pulmonary Fibrosis, HSP70 Heat-Shock Proteins, Hydrochloric Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH CounterACT Program, CounterACT Program, the National Institutes of Health Office of the Director (NIH OD), and the National Institute of Environmental Health Sciences (NIEHS).
Abstract (Originalsprache)
Combined therapies with Heat Shock Protein 90 (HSP90) inhibitors and Heat Shock Protein 70 (HSP70) inducers are gaining significant interest in cancer and cardiovascular research. Here, we tested the hypothesis that HSP90 inhibitors and HSP70 inducers, together, can block the development of pulmonary fibrosis. We exposed New Zealand White Rabbits to hydrochloric acid (HCl, 0.1 N, 1.5 mL/kg), one of the top five chemicals most commonly involved in accidental exposures and inhalation injuries worldwide, and treated animals with either the orally available HSP90 inhibitor TAS-116 (1.7 mg/kg 5x/week) or TAS-116 combined with the HSP70 inducer, geranylgeranyl acetone (GGA, 50 mg/kg, 3x/week). At 60 days post-HCl instillation, TAS and GGA treatment markedly reduced the degree of pulmonary fibrosis, lung dysfunction, and activation of profibrotic pathways. The use of HSP70 inducers may be a helpful tool to improve the profile of HSP90 inhibitors and reduce their minimal effective dose and side effects. Further investigation is required to explore the exact synergistic mechanism behind the antifibrotic profile of HSP90 inhibitors and HSP70 inducers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA 23508, USA.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA.
- School of Medicine, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA.
- Red Hawk Veterinary Services, Poplar Branch, NC 27965, USA.
- School of Medical Diagnostic & Translational Sciences, Ellmer College of Health Sciences, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA.
ORCID-Profile: Ruben M L Colunga Biancatelli, Pavel A Solopov, John D Catravas
Förderung
- NIEHS NIH HHS
- NIH CounterACT Program
- CounterACT Program, the National Institutes of Health Office of the Director (NIH OD), and the National Institute of Environmental Health Sciences (NIEHS)
Zitieren
APA
Colunga Biancatelli, R. M. L., Solopov, P. A., Day, T., Austin, D. E., Murray, L. E., & Catravas, J. D. (2025). Combination of HSP90 Inhibitors and HSP70 Inducers Prevent Hydrochloric Acid-Induced Pulmonary Fibrosis in Rabbits. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020441
Vancouver
Colunga Biancatelli RML, Solopov PA, Day T, Austin DE, Murray LE, Catravas JD. Combination of HSP90 Inhibitors and HSP70 Inducers Prevent Hydrochloric Acid-Induced Pulmonary Fibrosis in Rabbits. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020441
BibTeX
@article{ColungaBiancatelli2025,
author = {Colunga Biancatelli, Ruben M L and Solopov, Pavel A and Day, Tierney and Austin, Dan E and Murray, Len E and Catravas, John D},
title = {Combination of HSP90 Inhibitors and HSP70 Inducers Prevent Hydrochloric Acid-Induced Pulmonary Fibrosis in Rabbits},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020441}
}
EUVIMED